Related Experiment Video
Updated: Jun 22, 2026
11:49
Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application
Published on: March 8, 2019
Liquid-crystal intraocular adaptive lens with wireless control
Optics Express
|June 24, 2009
Summary
This study introduces an adaptive intraocular lens (IOL) using liquid-crystal technology for wireless visual correction. The novel adaptive IOL prototype demonstrates effective correction of ocular aberrations, offering improved vision quality.
Area of Science:
- Ophthalmology
- Biomedical Engineering
- Materials Science
Background:
- Intraocular lenses (IOLs) are crucial for vision correction after cataract surgery.
- Current IOLs have limitations in correcting dynamic visual aberrations.
- Adaptive optics offer potential for advanced visual correction.
Purpose of the Study:
- To develop and evaluate a prototype adaptive intraocular lens (IOL) with wireless control.
- To assess the IOL's capability for correcting ocular aberrations in vitro.
- To investigate the use of liquid-crystal spatial phase modulators for dynamic vision correction.
Main Methods:
- A modal liquid-crystal spatial phase modulator was integrated into an IOL design.
- The IOL utilized nematic liquid crystals sandwiched between specialized glass substrates.
- Wireless radio-frequency control was implemented for adjusting lens parameters.
- Shack-Hartmann wavefront sensing was used for in vitro performance evaluation.
Main Results:
- The 5-mm clear aperture prototype achieved an initial +12.5 diopter focusing power.
- Adjustable defocus up to 4 waves (approx. 2.51 diopters) was demonstrated.
- Correction of spherical aberration coefficients ranged from -0.8 to 0.67 waves.
- A frequency-switching technique improved response speed to a settling time of ~4 seconds.
Conclusions:
- The developed adaptive IOL prototype shows significant potential for dynamic vision correction.
- Liquid-crystal spatial phase modulation offers a viable method for adaptive optics in IOLs.
- Wireless control enhances the practicality and applicability of advanced IOLs.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...